Family Related Factors and Concurrent Heroin Use in Methadone Maintenance Treatment in China

Overview

Journal Subst Use Misuse

Publisher Informa Healthcare

Date 2018 Jan 30

PMID 29377736

Citations 8

Authors

Nan Feng

Chunqing Lin

Julie Hsieh

Keming Rou

Li Li

Affiliations

Soon will be listed here.

Abstract

Background: The use of heroin during Methadone Maintenance Treatment (MMT) is a challenging problem that contributes to poor treatment outcomes. Families may play an important role in addressing concurrent heroin use during MMT, especially in collectivist societies such as China.

Objectives: In this study, we explored the relationship between family-related factors and concurrent heroin use during MMT in China.

Methods: This study was conducted at 68 MMT clinics in five provinces of China. There were 2,446 MMT clients in the analysis. Demographic information, MMT dosage, family members' heroin use status, family support of MMT, family problem, and self-reported heroin use were collected in a cross-sectional survey. The most recent urinalysis of opiate use was obtained from clinical records.

Results: Of the 2,446 participants, 533 (21.79%) self-reported heroin use in the previous seven days or had a positive urine morphine test result in the clinic record. Participants whose family member[s] used heroin were 1.59 times (95% CI: 1.17, 2.15) more likely to use concurrently during treatment. Those with family members who totally support them on the MMT were less likely to use (AOR: 0.75, 95% CI: 0.60, 0.94). Having more family problems was positively associated with concurrent heroin use (AOR: 2.01, 95% CI: 1.03, 3.93).

Conclusions: The results highlight the importance of the family's role in concurrent heroin use during MMT programs. The study's findings may have implications for family-based interventions that address concurrent heroin use.

Citing Articles

Opioid relapse and its predictors among methadone maintenance patients: a multicenter, cross-sectional study in Vietnam.

Nguyen H, Dinh D Harm Reduct J. 2023; 20(1):136.

PMID: 37717002 PMC: 10505306. DOI: 10.1186/s12954-023-00872-0.

Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study.

Knight D, Nkya I, West N, Yang C, Kidorf M, Latkin C Addict Sci Clin Pract. 2023; 18(1):19.

PMID: 36973794 PMC: 10042396. DOI: 10.1186/s13722-023-00374-1.

Associations between relationship quality and treatment-related stress among couples receiving methadone for opioid use disorder.

Polenick C, Han B, Meyers S, Arnold T, Cotton B J Subst Abuse Treat. 2021; 132:108580.

PMID: 34400033 PMC: 8671149. DOI: 10.1016/j.jsat.2021.108580.

Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care.

Guillou-Landreat M, Levassor P, Guerlais M, Sebille V, Victorri-Vigneau C Int J Environ Res Public Health. 2021; 18(11).

PMID: 34071908 PMC: 8198158. DOI: 10.3390/ijerph18115749.

Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India.

Kermode M, Choudhurimayum R, Rajkumar L, Haregu T, Armstrong G Harm Reduct J. 2020; 17(1):68.

PMID: 32993646 PMC: 7523306. DOI: 10.1186/s12954-020-00413-z.

References

Tang Y, Hao W . Improving drug addiction treatment in China. Addiction. 2007; 102(7):1057-63. DOI: 10.1111/j.1360-0443.2007.01849.x. View

Cao X, Wu Z, Rou K, Pang L, Luo W, Wang C . [Characteristics and associated factors of long-term retention for methadone maintenance treatment patients]. Zhonghua Yu Fang Yi Xue Za Zhi. 2013; 46(11):995-8. View

Liu E, Wu Z, Liang T, Shen L, Zhong H, Wang B . [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2009; 42(12):875-8. View

Joseph H, Stancliff S, Langrod J . Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000; 67(5-6):347-64. View

Farre M, Mas A, Torrens M, Moreno V, Cami J . Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend. 2002; 65(3):283-90. DOI: 10.1016/s0376-8716(01)00171-5. View

Pang L, Hao Y, Mi G, Wang C, Luo W, Rou K . Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS. 2008; 21 Suppl 8:S103-7. DOI: 10.1097/01.aids.0000304704.71917.64. View

Lin C, Wu Z, Detels R . Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health. 2011; 125(5):269-74. PMC: 3112464. DOI: 10.1016/j.puhe.2011.01.009. View

Mattick R, Ali R, White J, OBrien S, Wolk S, Danz C . Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction. 2003; 98(4):441-52. DOI: 10.1046/j.1360-0443.2003.00335.x. View

DOLE V, Joseph H . Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978; 311:181-9. DOI: 10.1111/j.1749-6632.1978.tb16775.x. View

10.

Muller J, Desmond B . Ethical dilemmas in a cross-cultural context. A Chinese example. West J Med. 1992; 157(3):323-7. PMC: 1011287. View

11.

Cao X, Wu Z, Rou K, Li L, Lin C, Wang C . Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Drug Alcohol Depend. 2014; 145:87-93. DOI: 10.1016/j.drugalcdep.2014.09.776. View

12.

Lin C, Wu Z, Rou K, Yin W, Wang C, Shoptaw S . Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J Subst Abuse Treat. 2009; 38(2):119-27. PMC: 2814942. DOI: 10.1016/j.jsat.2009.09.002. View

13.

Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee S . Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet. 2010; 376(9740):551-63. PMC: 3682471. DOI: 10.1016/S0140-6736(10)60928-2. View

14.

Luo W, Wu Z, Wei X . Reliability and validity of the Chinese version of the addiction severity index. J Acquir Immune Defic Syndr. 2010; 53 Suppl 1:S121-5. PMC: 2818828. DOI: 10.1097/QAI.0b013e3181c7dfca. View

15.

Caplehorn J, Bell J, Kleinbaum D, Gebski V . Methadone dose and heroin use during maintenance treatment. Addiction. 1993; 88(1):119-24. DOI: 10.1111/j.1360-0443.1993.tb02769.x. View

16.

Magura S, Nwakeze P, Demsky S . Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998; 93(1):51-60. DOI: 10.1046/j.1360-0443.1998.931516.x. View

17.

Sofuoglu M, Gonzalez G, Poling J, Kosten T . Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2004; 29(4):713-27. DOI: 10.1081/ada-120026256. View

18.

Chen X, Fan R . The family and harmonious medical decision making: cherishing an appropriate Confucian moral balance. J Med Philos. 2010; 35(5):573-86. DOI: 10.1093/jmp/jhq046. View

19.

Ling W, Blakis M, Holmes E, KLETT C, Carter W . Restabilization with methadone after methadyl acetate maintenance. Arch Gen Psychiatry. 1980; 37(2):194-6. DOI: 10.1001/archpsyc.1980.01780150084009. View

20.

Goehl L, Nunes E, Quitkin F, Hilton I . Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse. 1993; 19(3):251-62. DOI: 10.3109/00952999309001617. View